Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese [letter]
- 26 July 1991
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 32 (1) , 135-136
- https://doi.org/10.1111/j.1365-2125.1991.tb05629.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- DEBRISOQUINE PHENOTYPE AND GENOTYPE IN CHINESEThe Lancet, 1989
- DISASSOCIATION BETWEEN DEBRISOQUINE HYDROXYLATION PHENOTYPE AND GENOTYPE AMONG CHINESEThe Lancet, 1989
- Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs.Proceedings of the National Academy of Sciences, 1988
- LOW FREQUENCY OF SLOW DEBRISOQUINE HYDROXYLATION IN A NATIVE CHINESE POPULATIONThe Lancet, 1987
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980